Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±Ù°üÄ¡·á ÈÄ ¹ß»ýÇÑ ÇÏ¾Ç½Å°æ ¼Õ»ó ȯÀÚ¿¡ ´ëÇÑ ºÐ¼®

Analysis of Patients with Mandibular Nerve Damage after Root Canal Therapy

±¸°­È¸º¹ÀÀ¿ë°úÇÐÁö 2011³â 27±Ç 3È£ p.327 ~ 336
ÀÌÁö¼ö, ¼ÛÁöÈñ, ±è¿µ°Ç, ±è¼ºÅÃ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁö¼ö ( Lee Ji-Soo ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
¼ÛÁöÈñ ( Song Ji-Hee ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±è¿µ°Ç ( Kim Young-Gun ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç
±è¼ºÅà( Kim Seong-Taek ) - ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇÐ ±¸°­³»°úÇб³½Ç

Abstract

Ä¡°ú¿¡¼­ ÀÓ»óÀûÀ¸·Î ½Å°æº´¼º ÅëÁõÀÌ ¹ß»ýÇÏ´Â °æ¿ì´Â ÁÖ·Î ÇϾǽŰæÀÌ ¼Õ»ó ¹ÞÀº °æ¿ìÀÌ¸ç ±× ¿øÀÎÀ¸·Î´Â ¹ßÄ¡, ÀΰøÄ¡¾Æ¸Å½Ä, ¾Ç¾È¸é ¼ö¼ú, Ä¡ÁÖÄ¡·á ¹× ±Ù°üÄ¡·á µîÀÌ ÀÖ´Ù. º» ¿¬±¸´Â ±Ù°üÄ¡·á ÈÄ ¹ß»ýÇÑ ÇÏ¾Ç½Å°æ ¼Õ»ó ȯÀÚÀÇ ½Å°æº´ÁõÀÇ ¿øÀΰú Áõ»ó¿¡ µû¶ó ¾à¹°Ä¡·á¸¦ ÅëÇØ °³¼±µÈ Á¤µµ¸¦ ºÐ¼®ÇØ º¸°íÀÚ ÇÏ¿´´Ù. ±Ù°üÄ¡·á ÈÄ ¹ß»ýÇÑ À̻󰨰¢ ¶Ç´Â ÅëÁõÀ» ÁÖ Áõ»óÀ¸·Î 2004³âºÎÅÍ 2011³â±îÁö ¿¬¼¼´ëÇб³ Ä¡°ú´ëÇк´¿ø ±¸°­³»°ú¿¡ ³»¿øÇÑ È¯ÀÚ Áß 32¸íÀÇ ÀÇ·á±â·ÏÀ» ºÐ¼®ÇÏ¿´°í, ¾à¹°Ä¡·á¸¦ ½ÃÇàÇÑ °æ¿ì ȯÀÚÀÇ Áõ»óÀÌ °³¼±µÈ Á¤µµ¸¦ Æò°¡ÇÏ¿´´Ù. ÃÊÁø½Ã °¨°¢ÀúÇÏ ¶Ç´Â °¨°¢ºÎÀüÀÇ Áõ»óÀ» È£¼ÒÇÑ ÃÑ 32¸íÀÇ È¯ÀÚ (³²ÀÚ 9¸í, ¿©ÀÚ 23¸í, Æò±Õ³ªÀÌ 44¼¼)¸¦ ºÐ¼®ÇÏ¿´´Ù. ½Å°æº´ÁõÀÇ ¹ß»ý ¿øÀÎÀº ±Ù°üÄ¡·á ½Ã ¸¶Ãë (46.9%), ±Ù°ü ³» Àû¿ëÇÑ ¾àÀç¿¡ ÀÇÇÑ È­ÇÐÀû ¼Õ»ó (25%), ±Ù°ü¼ö¼ú (15.6%), ±âŸ ¿øÀÎÀÌ ºÒºÐ¸íÇÑ °æ¿ì (12.5%) ¼øÀ¸·Î ¸¹¾Ò´Ù. ó¹æµÈ ¾à¹°Àº ½ºÅ×·ÎÀ̵å, Ç×°æ·ÃÁ¦, Ç׿ì¿ïÁ¦, ÁøÅëÁ¦ µîÀ̾ú°í, ȯÀÚÀÇ Áõ»óÀÌ °³¼±µÉ ¶§±îÁö ¾à¹° ¿ë·®Àº Á¶ÀýµÇ¾úÀ¸¸ç, ¾à¹° º¹¿ë ±â°£Àº 1ÁÖÀÏ¿¡¼­ 11°³¿ù±îÁö ´Ù¾çÇÏ¿´´Ù. Áõ»óÀÌ ³ªÅ¸³­ ºÎÀ§¿¡ µû¶ó ÇÏÄ¡Á¶½Å°æ ¼Õ»óÀ¸·Î ÀÎÇÑ Áõ»óÀ» ³ªÅ¸³»´Â ȯÀÚ°¡ 25¸í, ¼³½Å°æ ¼Õ»óÀ¸·Î ÀÎÇÑ Áõ»óÀ» ³ªÅ¸³»´Â ȯÀÚ°¡ 7¸íÀ̾úÀ¸¸ç, ¾à¹°Ä¡·á ÈÄ Áõ»óÀÌ °³¼±µÈ °æ¿ì°¡ 21¸í (66%), Áõ»ó °³¼±ÀÌ ¹Ì¹ÌÇϰųª ¾ø´Â °æ¿ì°¡ 11¸í (34%)À̾ú´Ù. ±× Áõ»óÀº °¨°¢ÀúÇÏ¿Í °¨°¢ºÎÀüÀ¸·Î ºÐ·ùÇÏ¿´°í, °¨°¢ÀúÇÏ´Â 67%, °¨°¢ºÎÀüÀº 65% °³¼±À» º¸¿´´Ù. ±Ù°üÄ¡·á¿Í ¿¬°üµÈ ÇÏ¾Ç½Å°æ ¼Õ»óÀ¸·Î ÀÎÇØ ½Å°æº´ÁõÀÌ ¹ß»ýµÈ °æ¿ì ¾à¹°Ä¡·á¸¦ ÅëÇÑ Áõ»ó °³¼±À» µµ¸ðÇØ º¼ ¼ö ÀÖ´Ù. ´Ù¸¸, ½Å°æº´ÁõÀÇ Á¾·ù¿Í ȸº¹ ¼öÁØÀº ½Å°æ ¼Õ»óÀÇ ¿øÀÎ, Á¤µµ¿Í ¼Õ»ó ¹ß»ý ÈÄ Ä¡·á ½Ã±â, óġ ¹æ¹ý µî¿¡ ÀÇÇØ ¿µÇâÀ» ¹ÞÀ¸¸ç, °¢°¢ÀÇ º¯¼ö¿¡ µû¶ó ÅëÁõ °­µµ³ª ȸº¹ Á¤µµ¿¡ Â÷ÀÌ°¡ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµÇ¹Ç·Î ÇâÈÄ ´õ ¸¹Àº °³Ã¼ ¼ö¿¡¼­ ´Ù¾çÇÑ º¯¼ö¿¡ ´ëÇÑ Á¤·®ÀûÀÎ ¿¬±¸°¡ ÇÊ¿äÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

Reported causes of mandibular nerve injury in relation to neuropathic pain in dentistry include extraction, dental implant surgery, oral and maxillofacial surgery, periodontal treatment, and root-canal therapy. This study analyzed the characteristics of pharmacologic management of neuropathy after root-canal therapy. 32 patients who complain of abnormal sensation or pain after root-canal therapy and were referred to Department of Oral Medicine and the Temporomandibular Joint and Orofacial Pain Clinic at the Dental Hospital of Yonsei University, Seoul, Korea from 2004 to 2011 enrolled in this analysis and improvement of symptom was evaluated after pharmacologic management. Thirty-two patients who had hypoesthesia or dysesthesia at the initial visit were analyzed(9 men, 23 women; mean age: 44 years). The causes of neuropathy were local anesthesia(46.9%), chemical trauma from the sealant in root-canal(25%), endodontic surgery(15.6%), and unknown causes(12.5%). Medications such as steroids, anticonvulsants, antidepressants, and analgesics were took for improvement of symptoms and titrated for a variety of period from 1 week to 11 months. It was found that neuropathy of the inferior alveolar nerve and the lingual nerve was in 25 and 7 patients. The improvement of neurosensory disturbance and no improvement after pharmacotherapy was in 21(66%) and 11(34%) patients respectively. The hypoesthesia and dysesthesia was improved 67% and 65% respectively. These results suggest that symptomatic improvement by pharmacologic management can be possible in patients with neuropathy after root-canal therapy. But improvement of symptoms was influenced by the causes and degree of nerve injury, the periods of pharmacotherapy, and the choice of treatment methods. So, further investigation is needed by quantitative measurement of more variables in more individuals.

Å°¿öµå

ÇÏÄ¡Á¶½Å°æ;¼³½Å°æ;±Ù°üÄ¡·á;½Å°æ¼Õ»ó;¾à¹°Ä¡·á
inferior alveolar nerve;lingual nerve;root-canal therapy;nerve injury;pharmacologic management

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI